Thio-oxindole derivatives

This invention relates to compounds which are agonists of the progesterone receptor which have the general structure: wherein: p1 R1, R2, R3, R4, R5 and Q are as defined herein, or a pharmaceutically acceptable salt thereof, as well as methods of using these compounds to induce contraception or trea...

Full description

Saved in:
Bibliographic Details
Main Authors EDWARDS JAMES P, ZHI LIN, JONES TODD K, ZHANG PUWEN, WROBEL JAY E, TEGLEY CHRISTOPHER M, MELENSKI EDWARD G, FENSOME ANDREW, KOKO MARCI C
Format Patent
LanguageEnglish
Published 04.12.2003
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This invention relates to compounds which are agonists of the progesterone receptor which have the general structure: wherein: p1 R1, R2, R3, R4, R5 and Q are as defined herein, or a pharmaceutically acceptable salt thereof, as well as methods of using these compounds to induce contraception or treat progesterone-related carcinomas and adenocarcinomas.
Bibliography:Application Number: US20030420276